Finance

Beta
Lists
ABBV34:BVMF
Abbvie Inc BDR
80,70 R$
0,00%
(0,00) 1D
26 հնս, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ABBV34...
Open
79,36 R$
High
80,70 R$
Low
79,36 R$
Mkt. cap
447,62 մլրդ
Avg. vol.
720,00
Volume
264,00
52-wk high
80,70 R$
52-wk low
58,81 R$
Shares outstanding
1,77 մլրդ
No. of employees
57 հզր
Open
79,36 R$
High
80,70 R$
Low
79,36 R$
Mkt. cap
447,62 մլրդ
Avg. vol.
720,00
Volume
264,00
52-wk high
80,70 R$
52-wk low
58,81 R$
Shares outstanding
1,77 մլրդ
No. of employees
57 հզր
News stories
From sources across the web
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie Inc BDR
CEORobert A. Michael
Employees57 հզր
Founded10 ապր, 2012 թ.
HeadquartersՆորթ Չիկագո, Իլինոյս, Միացյալ Նահանգներ
Sector-
Websiteabbvie.com
Last report
29 ապր, 2026 թ.
Fiscal period
Q1 2026
EPS / Est. (USD)
2,65 $ / 2,67 $
-0,77%miss
Revenue / Est. (USD)
15,00 մլրդ / 14,72 մլրդ
+1,93%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
15,42 մլրդ
15,78 մլրդ
16,62 մլրդ
15,00 մլրդ
Cost of goods sold
4,35 մլրդ
4,46 մլրդ
4,55 մլրդ
4,22 մլրդ
Cost of revenue
4,35 մլրդ
4,46 մլրդ
4,55 մլրդ
4,22 մլրդ
Research and development expenses
2,13 մլրդ
2,29 մլրդ
2,58 մլրդ
2,47 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,18 մլրդ
3,43 մլրդ
3,82 մլրդ
3,49 մլրդ
Operating expense
5,29 մլրդ
5,72 մլրդ
6,40 մլրդ
5,96 մլրդ
Total operating expenses
9,64 մլրդ
10,18 մլրդ
10,95 մլրդ
10,18 մլրդ
Operating income
5,79 մլրդ
5,60 մլրդ
5,67 մլրդ
4,82 մլրդ
Other non operating income
91,00 մլն
199,00 մլն
120,00 մլն
-21,00 մլն
EBT including unusual items
1,55 մլրդ
714,00 մլն
2,67 մլրդ
1,04 մլրդ
EBT excluding unusual items
5,18 մլրդ
5,11 մլրդ
5,12 մլրդ
4,17 մլրդ
Income tax expense
613,00 մլն
526,00 մլն
853,00 մլն
342,00 մլն
Effective tax rate
39,45%
73,67%
31,97%
32,92%
Other operating expenses
-24,00 մլն
-
-
-
Net income
938,00 մլն
186,00 մլն
1,82 մլրդ
695,00 մլն
Net profit margin
6,08%
1,18%
10,93%
4,63%
Earnings per share
2,97
1,86
2,71
2,65
Interest and investment income
62,00 մլն
72,00 մլն
59,00 մլն
72,00 մլն
Interest expense
-740,00 մլն
-739,00 մլն
-714,00 մլն
-717,00 մլն
Net interest expenses
-678,00 մլն
-667,00 մլն
-655,00 մլն
-645,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
7,84 մլրդ
7,66 մլրդ
7,66 մլրդ
6,76 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of ABBV34
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more